FI63335B - Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne - Google Patents

Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne Download PDF

Info

Publication number
FI63335B
FI63335B FI790350A FI790350A FI63335B FI 63335 B FI63335 B FI 63335B FI 790350 A FI790350 A FI 790350A FI 790350 A FI790350 A FI 790350A FI 63335 B FI63335 B FI 63335B
Authority
FI
Finland
Prior art keywords
tablets
eudragit
molecular weight
active ingredient
release
Prior art date
Application number
FI790350A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI790350A (fi
Inventor
Gunnar Aslak Sothmann
Esko Veikko Marttila
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Priority to FI790350A priority Critical patent/FI63335B/fi
Priority to NO794290A priority patent/NO149490B/no
Priority to AT80300008T priority patent/ATE20182T1/de
Priority to DE8080300008T priority patent/DE3071625D1/de
Priority to EP80300008A priority patent/EP0014514B1/de
Priority to MX10140380U priority patent/MX6499E/es
Priority to US06/111,962 priority patent/US4351825A/en
Priority to PT70719A priority patent/PT70719A/pt
Priority to DK28480A priority patent/DK28480A/da
Priority to JP641580A priority patent/JPS55129222A/ja
Priority to CA000344502A priority patent/CA1144071A/en
Priority to ZA00800553A priority patent/ZA80553B/xx
Priority to GR61091A priority patent/GR65623B/el
Priority to IE202/80A priority patent/IE51741B1/en
Priority to ES488168A priority patent/ES488168A0/es
Publication of FI790350A publication Critical patent/FI790350A/fi
Priority to AR279792A priority patent/AR222207A1/es
Application granted granted Critical
Publication of FI63335B publication Critical patent/FI63335B/fi
Priority to FI890270A priority patent/FI890270A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI790350A 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne FI63335B (fi)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
NO794290A NO149490B (no) 1979-02-02 1979-12-27 Fremgangsmaate ved fremstilling av tabletter med regulert frigjoerelse av den aktive bestanddel
AT80300008T ATE20182T1 (de) 1979-02-02 1980-01-02 Verfahren zur herstellung von tabletten.
DE8080300008T DE3071625D1 (en) 1979-02-02 1980-01-02 Process for the preparation of tablets
EP80300008A EP0014514B1 (de) 1979-02-02 1980-01-02 Verfahren zur Herstellung von Tabletten
US06/111,962 US4351825A (en) 1979-02-02 1980-01-14 Process for the preparation of tablets with retarded liberation of the active agent is predetermined
MX10140380U MX6499E (es) 1979-02-02 1980-01-14 Procedimiento para la elaboracion de tabletas tipo matriz,con liberacion retardada del principio activo
DK28480A DK28480A (da) 1979-02-02 1980-01-23 Fremgangsmaade til fremstilling af tabletter med forsinket frigivelse af det aktive middel i hvilke tabletter frigivelseshastigheden for det aktive middel er fastlagt i forvejen
PT70719A PT70719A (en) 1979-02-02 1980-01-23 Process for the preparation of tablets with retarded liberation of the active agent in which tablets the rate of liberation of the active agent is predetermined
JP641580A JPS55129222A (en) 1979-02-02 1980-01-24 Manufacture of tablet
CA000344502A CA1144071A (en) 1979-02-02 1980-01-28 Process for the preparation of tablets with retarded liberation of the active agent, in which tablets the rate of liberation of the active agent is predetermined
ZA00800553A ZA80553B (en) 1979-02-02 1980-01-30 Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined
GR61091A GR65623B (en) 1979-02-02 1980-01-31 Method for the preparation of tablets with delayed release of drastic constituent,inwhich tablets the rhytus of the release of drastic constituent is predetermined
IE202/80A IE51741B1 (en) 1979-02-02 1980-02-01 Process for the preparation of tablets
ES488168A ES488168A0 (es) 1979-02-02 1980-02-01 Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
AR279792A AR222207A1 (es) 1979-02-02 1980-12-30 Proceso para la preparacion de tabletas tipo matriz con liberacion retardada del agente activo
FI890270A FI890270A (fi) 1979-02-02 1989-01-18 Foerfarande foer framstaellning av tabletter, som retarderat frigoer effektivaemne.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
FI790350 1979-02-02

Publications (2)

Publication Number Publication Date
FI790350A FI790350A (fi) 1980-08-03
FI63335B true FI63335B (fi) 1983-02-28

Family

ID=8512353

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne

Country Status (15)

Country Link
US (1) US4351825A (de)
EP (1) EP0014514B1 (de)
JP (1) JPS55129222A (de)
AR (1) AR222207A1 (de)
AT (1) ATE20182T1 (de)
CA (1) CA1144071A (de)
DE (1) DE3071625D1 (de)
DK (1) DK28480A (de)
ES (1) ES488168A0 (de)
FI (1) FI63335B (de)
GR (1) GR65623B (de)
IE (1) IE51741B1 (de)
NO (1) NO149490B (de)
PT (1) PT70719A (de)
ZA (1) ZA80553B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
IL96311A (en) † 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5431630A (en) * 1993-09-07 1995-07-11 Surgic-Acid, Inc. Needle guard and nonreusable syringe
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6776996B2 (en) 1997-07-09 2004-08-17 Basf Aktiengesellschaft Pesticidal matrices
ID20839A (id) * 1997-07-09 1999-03-11 American Cyanamid Co Bahan acuan pestisida berlapis lebih baik, pengolahan pada pembuatannya serta komposisi-komposisi yang terkandung di dalamnya
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CN1203846C (zh) 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1949890A3 (de) 1999-06-04 2011-05-18 ALZA Corporation Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
HUP0201626A3 (en) * 1999-06-04 2004-05-28 Alza Corp Mountain View Implantable gel compositions and method of manufacture
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP1549296A4 (de) * 2002-08-02 2006-08-09 Penwest Pharmaceuticals Co Metformin-formulierungen mit verzögerter freisetzung
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
SE353229B (de) * 1970-06-04 1973-01-29 Haessle Ab
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS6191314A (ja) * 1984-10-12 1986-05-09 Nippon Kokan Kk <Nkk> 取鍋精錬炉による溶鋼の精錬方法

Also Published As

Publication number Publication date
NO794290L (no) 1980-08-05
AR222207A1 (es) 1981-04-30
CA1144071A (en) 1983-04-05
ATE20182T1 (de) 1986-06-15
FI790350A (fi) 1980-08-03
EP0014514A2 (de) 1980-08-20
PT70719A (en) 1980-02-01
GR65623B (en) 1980-10-15
DK28480A (da) 1980-08-03
ES8102702A1 (es) 1981-02-16
ES488168A0 (es) 1981-02-16
US4351825A (en) 1982-09-28
EP0014514B1 (de) 1986-06-04
DE3071625D1 (en) 1986-07-10
JPS55129222A (en) 1980-10-06
IE51741B1 (en) 1987-03-18
EP0014514A3 (en) 1981-06-10
ZA80553B (en) 1981-02-25
IE800202L (en) 1980-08-02
NO149490B (no) 1984-01-23

Similar Documents

Publication Publication Date Title
FI63335B (fi) Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4970075A (en) Controlled release bases for pharmaceuticals
FI87045C (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart
DE69432618T2 (de) Arzneimittel mit gesteuertem Beginn und gesteuerter Rate der Freisetzung
DE69535426T2 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
KR100203339B1 (ko) 의약용 방출조절 매트릭스
CA1303504C (en) Pharmaceutical formulation containing acrivastine
DE642785T1 (de) Heterodisperse Hydrogelsysteme zur verzögerten Freisetzung unlöslicher Arzneistoffe.
CA2637444C (en) Coated pharmaceutical composition of tolterodine or a salt thereof having rapid dissolution at acidic conditions and slow dissolution at higher ph values
WO2006108519A1 (de) Kombination zur therapie bei benigner prostatahyperplasie
JPH07558B2 (ja) モピダモール製剤
EP1293208A1 (de) Arzneizusammensetzung
US3459850A (en) Sustained-release tablets,a process and a composition for their preparation
EP2863891A1 (de) Arzneiform zur verlängerten freisetzung von wirkstoffen
RU2004127237A (ru) Твердая препаративная форма с замедленным/контролируемым высвобождением как новая система доставки лекарственного средства со сниженным риском демпинга дозы
CA2416771C (en) 5-methyl-2-(2&#39;-chloro-6&#39;-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
DE4310963C2 (de) Retardmikrotablette von beta-Phenylpropiophenonderivaten
Ibrahim et al. Preformulation-assisted design and characterization of modified release gastroretentive floating extrudates towards improved bioavailability and minimized side effects of baclofen
Mulye et al. Use of dicalcium phosphate dihydrate for sustained release of highly water soluble drugs
EP1088554A1 (de) Zusammensetzung mit kontrollierter Freigabe enthaltend 5-Isosorbidnitrat und Acetylsalicylsäure
JPH0460090B2 (de)
AU2019254487B2 (en) Sustained release pyridostigmine compositions
Tarkase et al. FORMULATION ASPECTS BY APPROACHING DIFFERENT POLYMERS OVER MATRIX TABLETS
Patel et al. Studies in Formulation Development of Low Dose Content Drug Using Fluid Bed Granulation Technique
DE19619313A1 (de) Zubereitung mit retardierter Wirkstofffreisetzung

Legal Events

Date Code Title Description
FC Application refused

Owner name: ORION-YHTYMAE OY